APLS stock

Apellis Pharmaceuticals Inc (APLS) valuation · rev $1.00B

Apellis Pharmaceuticals Inc (APLS) rev $1.00B.

Cached valuation scalars
MetricValue
Market cap$2.29B
Revenue$1.00B
P/S2.3
These valuation metrics as JSON? API free 100/day

APLS valuation FAQ

What is APLS's market cap?

Apellis Pharmaceuticals Inc (APLS) market cap is $2.29B on the latest cached fundamentals snapshot.

What is APLS's latest revenue?

Latest cached Apellis Pharmaceuticals Inc (APLS) revenue was $1.00B. Statements: https://lician.com/financials/apls

What is APLS's price-to-sales ratio?

Apellis Pharmaceuticals Inc (APLS) price-to-sales (P/S) is 2.3, cached market cap $2.29B divided by revenue $1.00B.

How many APLS valuation scalars are listed on this page?

This page lists 3 cached valuation scalars for Apellis Pharmaceuticals Inc (APLS): Market cap, Revenue, and P/S.

Where is APLS valuation listed?

Cached valuation multiples for Apellis Pharmaceuticals Inc (APLS) are listed at https://lician.com/valuation/apls.

Not investment advice. Cached rows, not a live tape.